HLA compatibility and cardiac transplant recipient survival.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Annals of Thoracic Surgery

• Publication date

  1987-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0003-4975(10)62062-0PMID 3307658
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CORRELATION OF HLA MATCHING WITH KIDNEY GRAFT SURVIVAL IN PATIENTS WITH OR WITHOUT CYCLOSPORINE TREATMENT: FOR THE COLLABORATIVE TRANSPLANT STUDY

  1985cited by this paper
• MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.

  1979cited by this paper
• Immunogenetics and Immunodeficiency

  1975cited by this paper
• The Nature and Function of Histocompatibility-linked Immune Response Genes

  1975cited by this paper
• Localization of genes on human chromosomes by studies of human-Chinese hamster somatic cell hybrids

  1973cited by this paper
• A generalized two-sample Wilcoxon test for doubly censored data.

  1965cited by this paper

• Donor-recipient Matching in Heart Transplantation

  2020cites this paper
• HLA‐EMMA, a tool for molecular‐level HLA matching after heart transplantation

  2020cites this paper
• Molecular‐level HLA mismatch is associated with rejection and worsened graft survival in heart transplant recipients – a retrospective study

  2020cites this paper
• History of the Southern Thoracic Surgical Association President's Award for Best Scientific Paper.

  2018cites this paper
• Immunological risk factors in heart transplantation

  2016cites this paper
• HLA molecular epitope mismatching and long-term graft loss in pediatric heart transplant recipients.

  2015cites this paper
• Human leukocyte antigen matching in heart transplantation: systematic review and meta‐analysis

  2014cites this paper
• Cardiovascular Risk Factors in Cardiac Transplant Recipients

  2008cites this paper
• Current outcomes following heart transplantation.

  2004cites this paper
• The effect of novel immunosuppressants on extracellular matrix remodelling and the expression of fibrosis associated genes in an experimental model of allograft vasculopathy

  2003cites this paper
• Adult cardiac surgery during the first 50 years of the Southern Thoracic Surgical Association.

  2003cites this paper
• Heart allograft vascular disease: an obliterative vascular disease in transplanted hearts.

  1999cites this paper
• Ten-year heart transplantation experience at the MARITIME HEART CENTER: does volume affect results?

  1999cites this paper
• Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts.

  1998cites this paper
• Implication of HLA mismatch in the clinical outcome of orthotopic heart transplantation.

  1998cites this paper
• Immunogenetics of Heart Transplantation in Rodents

  1997cites this paper
• Diagnosis and Management of Cardiac Allograft Vasculopathy (Chronic Rejection)

  1996cites this paper
• Excellent outcome of cardiac transplantation using domino donor hearts.

  1996cites this paper
• Pretransplant Immunological Considerations

  1996cites this paper
• Coronary artery intimal thickening in the transplanted heart. An in vivo intracoronary untrasound study of immunologic and metabolic risk factors.

  1996cites this paper
• Cardiac Transplantation: A Review

  1995cites this paper
• Reduction of cellular rejection and increase in longer-term survival after heart transplantation after HLA-DR matching.

  1995cites this paper
• Effect of crossmatching on outcome in organ transplantation.

  1995cites this paper
• Cardiac transplant donor heart allocation based on prospective tissue matching.

  1994cites this paper
• Cardiac transplantation: The Stanford experience in the cyclosporine era

  1994cites this paper
• THE RELATIONSHIP AMONG DONOR‐RECIPIENT HLA MISMATCHES, REJECTION, AND DEATH FROM CORONARY ARTERY DISEASE IN CARDIAC TRANSPLANT RECIPIENTS1

  1994cites this paper
• Cardiac transplantation: the Stanford experience in the cyclosporine era.

  1994cites this paper
• REJECTION IN HEART TRANSPLANTATION STRONGLY CORRELATES WITH HLA‐DR ANTIGEN MISMATCH

  1994cites this paper
• HLA matching and cardiac transplantation.

  1994cites this paper
• Toward a Rational Design of Clinical Trials of Immunosuppressive Agents in Transplantation

  1993cites this paper
• Cardiac transplantation: surgical considerations and early postoperative management.

  1992cites this paper
• Techniques of immunosuppression after cardiac transplantation.

  1992cites this paper
• Morbidity risk factors in human cardiac transplantation. Histoincompatibility and protracted graft ischemia entail high risk of rejection and infection.

  1992cites this paper
• Heart and heart-lung transplantation.

  1992cites this paper
• Analyzing the number of "rejection episodes" in renal transplant studies.

  1992cites this paper
• Histocompatibility and other risk factors for histological rejection of human cardiac allografts during the first three months following transplantation.

  1991cites this paper
• Long-term complications of cardiac transplantation.

  1991cites this paper
• Accelerated coronary atherosclerosis in cardiac transplantation.

  1991cites this paper
• Getting the most mileage from donated hearts.

  1990cites this paper
• Influence of human leukocyte antigen matching in cardiac transplantation.

  1990cites this paper
• Late complications in pediatric cardiac transplant recipients.

  1990cites this paper
• HLA compatibility and clinical outcome among cardiac transplant recipients

  1990cites this paper
• HLA histocompatibility affects cardiac transplant rejection and may provide one basis for organ allocation.

  1990cites this paper
• Heart and heart-lung transplantation.

  1989cites this paper
• The influence of ABO blood groups on the incidence of cardiac allograft rejection in males.

  1989cites this paper
• Treatment with cyclosporin and risks of graft rejection in male kidney and heart transplant recipients with non-O blood.

  1988cites this paper
• Human heart transplantation. Rejection risk factors.

  1988cites this paper
• The treatment of advanced cardiac allograft rejection.

  1988cites this paper
• Long-term hemodynamic results after cardiac transplantation.

  1987cites this paper